|
US20020192198A1
(en)
*
|
1998-04-21 |
2002-12-19 |
Elia James P. |
Method for growing human organs and suborgans
|
|
US20030157074A1
(en)
*
|
1994-11-16 |
2003-08-21 |
Mitrani Eduardo N. |
Vitro micro-organs, and uses related thereto
|
|
US5980887A
(en)
*
|
1996-11-08 |
1999-11-09 |
St. Elizabeth's Medical Center Of Boston |
Methods for enhancing angiogenesis with endothelial progenitor cells
|
|
US8075880B2
(en)
*
|
1999-01-11 |
2011-12-13 |
Steward St. Elizabeth's Medical Center Of Boston, Inc. |
Compositions and methods for regulating angiogenesis
|
|
US6486133B1
(en)
|
1997-03-07 |
2002-11-26 |
The Wistar Institute Of Anatomy And Biology |
Methods for inducing localized vascular development and enhancing the repair of a wound in the mammamian dermis
|
|
DE69821011T3
(de)
*
|
1997-10-02 |
2009-01-08 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Verfahren zur Modulierung der Neovaskularisierung und/oder des Wachstums kollateraler Arterien und/oder anderer Arterien aus bestehenden arteriolären Verbindungen
|
|
US6749617B1
(en)
*
|
1997-11-04 |
2004-06-15 |
Scimed Life Systems, Inc. |
Catheter and implants for the delivery of therapeutic agents to tissues
|
|
US7687057B2
(en)
*
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
|
CA2311729A1
(en)
*
|
1998-01-23 |
1999-07-29 |
Imclone Systems Incorporated |
Purified populations of stem cells
|
|
CA2322559C
(en)
*
|
1998-03-09 |
2012-07-17 |
St. Elizabeth's Medical Center |
Compositions and methods for modulating vascularization
|
|
US6676937B1
(en)
*
|
1998-03-09 |
2004-01-13 |
Caritas St. Elizabeth's Medical Center Of Boston Inc. |
Compositions and methods for modulating vascularization
|
|
US20040228834A1
(en)
*
|
1998-03-09 |
2004-11-18 |
Jeffrey Isner |
Compositions and methods for modulating vascularization
|
|
US9585916B2
(en)
|
1999-03-26 |
2017-03-07 |
Northern Therapeutics Inc. |
Cell based therapy for the pulmonary system
|
|
CA2266805C
(en)
|
1998-03-27 |
2015-04-28 |
An-Go-Gen Inc. |
Cell-based gene therapy in the treatment of pulmonary disorders
|
|
US6482406B1
(en)
|
1999-03-26 |
2002-11-19 |
Duncan J. Stewart |
Cell-based gene therapy for the pulmonary system
|
|
US6620382B1
(en)
*
|
1998-05-22 |
2003-09-16 |
Biopheresis Technologies, Llc. |
Method and compositions for treatment of cancers
|
|
US8197430B1
(en)
|
1998-05-22 |
2012-06-12 |
Biopheresis Technologies, Inc. |
Method and system to remove cytokine inhibitor in patients
|
|
WO2000002998A1
(en)
|
1998-07-10 |
2000-01-20 |
Brigham & Women's Hospital, Inc. |
Methods for implanting cells
|
|
US7030083B2
(en)
*
|
1998-09-09 |
2006-04-18 |
University Of Washington |
Treatment of eclampsia and preeclampsia
|
|
US6677300B1
(en)
*
|
1998-09-09 |
2004-01-13 |
Scios, Inc. |
Treatment of microvascular angiopathies
|
|
EP1568375A1
(en)
*
|
1998-10-26 |
2005-08-31 |
Ludwig Institute For Cancer Research |
Use of VEGF-C or VEGF-D gene or protein to prevent restenosis
|
|
US6958147B1
(en)
|
1998-10-26 |
2005-10-25 |
Licentia Ltd |
Use of VEGF-C to prevent restenosis
|
|
EP1126870B1
(en)
*
|
1998-10-26 |
2004-09-08 |
Ludwig Institute For Cancer Research |
Use of vegf-c or vegf-d gene or protein to prevent restenosis
|
|
DE19850986A1
(de)
*
|
1998-11-05 |
2000-05-25 |
Aventis Pharma Gmbh |
Die gentechnische Prägung von Zellen und ihre Verwendung zur Prophylaxe und Therapie von Erkrankungen
|
|
CA2351671A1
(en)
|
1998-11-24 |
2000-06-08 |
Regents Of The University Of Minnesota |
Transgenic circulating endothelial cells
|
|
US20040131601A1
(en)
*
|
2000-03-30 |
2004-07-08 |
Foundry Networks, Inc., A Delaward Corporation |
Injection of bone marrow-derived cells and medium for angiogenesis
|
|
US6348050B1
(en)
*
|
1999-04-30 |
2002-02-19 |
Medtronic, Inc. |
Infusion systems for creating microenvironments in a living body
|
|
US20030152562A1
(en)
*
|
2001-10-23 |
2003-08-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Vitro micro-organs, and uses related thereto
|
|
AU2003901668A0
(en)
*
|
2003-03-28 |
2003-05-01 |
Medvet Science Pty. Ltd. |
Non-haemopoietic precursor cells
|
|
US7670628B2
(en)
*
|
1999-07-07 |
2010-03-02 |
Angioblast Systems, Inc. |
Mesenchymal precursor cell
|
|
AUPQ147799A0
(en)
*
|
1999-07-07 |
1999-07-29 |
Medvet Science Pty. Ltd. |
Mesenchymal precursor cell
|
|
US8062675B2
(en)
|
1999-07-07 |
2011-11-22 |
Angioblast Systems, Inc. |
Mesenchymal precursor cell
|
|
US20050158289A1
(en)
*
|
1999-07-07 |
2005-07-21 |
Simmons Paul J. |
Mesenchymal precursor cell and use thereof in the repair of bone defects and fractures in mammals
|
|
EP1210102B1
(en)
*
|
1999-08-19 |
2010-04-07 |
Applied Protein Sciences, LLC |
Tgf-alpha polypeptides, functional fragments and methods of use therefor
|
|
US20020193301A1
(en)
|
1999-08-19 |
2002-12-19 |
Stem Cell Pharmaceuticals, Inc. |
TGF-alpha polypeptides, functional fragments and methods of use therefor
|
|
JP2003509463A
(ja)
*
|
1999-09-23 |
2003-03-11 |
アン−ゴー−ジェン インコーポレーテッド |
肺系のための細胞ベースの遺伝子治療
|
|
EP1142590B8
(en)
*
|
1999-10-29 |
2008-11-26 |
AnGes MG, Inc. |
Gene therapy for diabetic ischemic disease
|
|
US6379708B1
(en)
*
|
1999-11-20 |
2002-04-30 |
Cytologic, Llc |
Method for enhancing immune responses in mammals
|
|
US20030229393A1
(en)
*
|
2001-03-15 |
2003-12-11 |
Kutryk Michael J. B. |
Medical device with coating that promotes cell adherence and differentiation
|
|
US8088060B2
(en)
*
|
2000-03-15 |
2012-01-03 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
|
ATE362382T1
(de)
|
2000-03-15 |
2007-06-15 |
Orbusneich Medical Inc |
Beschichtung welche ein anhaften von endothelzellen stimuliert
|
|
US9522217B2
(en)
*
|
2000-03-15 |
2016-12-20 |
Orbusneich Medical, Inc. |
Medical device with coating for capturing genetically-altered cells and methods for using same
|
|
US8460367B2
(en)
*
|
2000-03-15 |
2013-06-11 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
|
US20070055367A1
(en)
*
|
2000-03-15 |
2007-03-08 |
Orbus Medical Technologies, Inc. |
Medical device with coating that promotes endothelial cell adherence and differentiation
|
|
US20030104977A1
(en)
*
|
2000-03-31 |
2003-06-05 |
Ugo Ripamonti |
Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
|
|
US7166280B2
(en)
*
|
2000-04-06 |
2007-01-23 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
|
|
US20070111935A1
(en)
*
|
2000-04-06 |
2007-05-17 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
|
|
US9694038B2
(en)
*
|
2000-04-06 |
2017-07-04 |
Wayne P. Franco |
Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
|
|
US10281478B2
(en)
|
2000-04-06 |
2019-05-07 |
Wayne P. Franco |
Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
|
|
US20050277576A1
(en)
*
|
2000-04-06 |
2005-12-15 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
|
|
US20100303769A1
(en)
*
|
2000-04-06 |
2010-12-02 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
|
|
US6800298B1
(en)
*
|
2000-05-11 |
2004-10-05 |
Clemson University |
Biological lubricant composition and method of applying lubricant composition
|
|
CA2412436C
(en)
*
|
2000-06-05 |
2013-05-21 |
The Trustees Of Columbia University In The City Of New York |
Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
|
|
US6878371B2
(en)
*
|
2000-07-26 |
2005-04-12 |
Boston Scientific Scimed, Inc. |
Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue
|
|
EP1383551B1
(en)
*
|
2000-11-08 |
2010-07-14 |
Boston Scientific Limited |
Multilumen catheter and implants for the delivery of therapeutic agents to tissues
|
|
US7029209B2
(en)
|
2000-12-18 |
2006-04-18 |
Cardemon, Inc. |
Slidable boring tool with fine adjustment
|
|
AU2002356180A1
(en)
*
|
2001-08-06 |
2003-03-10 |
The Regents Of The University Of California |
Methods for inhibiting angiogenesis
|
|
WO2003013570A1
(en)
*
|
2001-08-09 |
2003-02-20 |
Cornell Research Foundation, Inc. |
Platelet-derived growth factor protection of cardiac myocardium
|
|
US7217570B2
(en)
*
|
2001-08-23 |
2007-05-15 |
The Wistar Institute Of Anatomy And Biology |
Organotypic intestinal culture and methods of use thereof
|
|
US20030054331A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Stemsource, Inc. |
Preservation of non embryonic cells from non hematopoietic tissues
|
|
US20040031067A1
(en)
*
|
2001-10-11 |
2004-02-12 |
Meenhard Herlyn |
Regulation of human skin healing
|
|
US20040044403A1
(en)
*
|
2001-10-30 |
2004-03-04 |
Joyce Bischoff |
Tissue-engineered vascular structures
|
|
WO2003039382A2
(en)
*
|
2001-11-05 |
2003-05-15 |
Medgenics, Inc. |
System for processing tissue
|
|
US8608661B1
(en)
|
2001-11-30 |
2013-12-17 |
Advanced Cardiovascular Systems, Inc. |
Method for intravascular delivery of a treatment agent beyond a blood vessel wall
|
|
US7771716B2
(en)
|
2001-12-07 |
2010-08-10 |
Cytori Therapeutics, Inc. |
Methods of using regenerative cells in the treatment of musculoskeletal disorders
|
|
US20050048035A1
(en)
|
2001-12-07 |
2005-03-03 |
Fraser John K. |
Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
|
|
US20050008626A1
(en)
*
|
2001-12-07 |
2005-01-13 |
Fraser John K. |
Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
|
|
US7595043B2
(en)
*
|
2001-12-07 |
2009-09-29 |
Cytori Therapeutics, Inc. |
Method for processing and using adipose-derived stem cells
|
|
US9597395B2
(en)
|
2001-12-07 |
2017-03-21 |
Cytori Therapeutics, Inc. |
Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
|
|
US20060204556A1
(en)
*
|
2001-12-07 |
2006-09-14 |
Cytori Therapeutics, Inc. |
Cell-loaded prostheses for regenerative intraluminal applications
|
|
US20050095228A1
(en)
|
2001-12-07 |
2005-05-05 |
Fraser John K. |
Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
|
|
US7651684B2
(en)
*
|
2001-12-07 |
2010-01-26 |
Cytori Therapeutics, Inc. |
Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
|
|
JP4653952B2
(ja)
|
2001-12-07 |
2011-03-16 |
サイトリ セラピューティクス インコーポレイテッド |
処理済み脂肪吸引細胞で患者を治療するためのシステムと方法
|
|
US7514075B2
(en)
*
|
2001-12-07 |
2009-04-07 |
Cytori Therapeutics, Inc. |
Systems and methods for separating and concentrating adipose derived stem cells from tissue
|
|
US7585670B2
(en)
|
2001-12-07 |
2009-09-08 |
Cytori Therapeutics, Inc. |
Automated methods for isolating and using clinically safe adipose derived regenerative cells
|
|
US8404229B2
(en)
*
|
2001-12-07 |
2013-03-26 |
Cytori Therapeutics, Inc. |
Methods of using adipose derived stem cells to treat acute tubular necrosis
|
|
EP1467746A4
(en)
*
|
2001-12-20 |
2006-10-04 |
Macropore Inc |
SYSTEMS AND METHODS FOR TREATING PATIENTS WITH COLLAGEN-RICH MATERIAL EXTRACTED FROM ADIPOSE TISSUES
|
|
EP1465983B1
(en)
*
|
2001-12-21 |
2010-03-31 |
Immunex Corporation |
Endothelial stem cells, populations, methods of isolation and use thereof
|
|
US20030139333A1
(en)
*
|
2002-01-18 |
2003-07-24 |
Genetix Pharmaceuticals, Inc. |
Methods and compositions for promoting angiogenesis
|
|
US20040009146A1
(en)
*
|
2002-02-26 |
2004-01-15 |
Osvaldo Podhajcer |
Anti-tumor vaccine and method
|
|
US20030199464A1
(en)
*
|
2002-04-23 |
2003-10-23 |
Silviu Itescu |
Regeneration of endogenous myocardial tissue by induction of neovascularization
|
|
US7361368B2
(en)
|
2002-06-28 |
2008-04-22 |
Advanced Cardiovascular Systems, Inc. |
Device and method for combining a treatment agent and a gel
|
|
US20040009158A1
(en)
*
|
2002-07-11 |
2004-01-15 |
Washington University |
Promotion of neovascularization using bone marrow-derived endothelial-progenitor cells
|
|
US20040052771A1
(en)
*
|
2002-07-12 |
2004-03-18 |
Lim Sai Kiang |
Hemangioblast progenitor cells
|
|
US20060165666A1
(en)
*
|
2002-07-12 |
2006-07-27 |
Lim Sai K |
Hemangioblast progenitor cells
|
|
AU2003242967A1
(en)
*
|
2002-07-12 |
2004-02-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method and device for inducing biological processes by micro-organs
|
|
DE10234192B4
(de)
*
|
2002-07-26 |
2009-11-26 |
Epoplus Gmbh Co.Kg |
Verwendung von Erythropoetin
|
|
US20040037811A1
(en)
*
|
2002-08-22 |
2004-02-26 |
The Cleveland Clinic Foundation |
Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy
|
|
US20050271639A1
(en)
*
|
2002-08-22 |
2005-12-08 |
Penn Marc S |
Genetically engineered cells for therapeutic applications
|
|
US7470538B2
(en)
*
|
2002-12-05 |
2008-12-30 |
Case Western Reserve University |
Cell-based therapies for ischemia
|
|
WO2004052177A2
(en)
*
|
2002-12-05 |
2004-06-24 |
Case Western Reserve University |
Cell-based therapies for ischemia
|
|
US7060684B1
(en)
|
2002-12-16 |
2006-06-13 |
Quijano Rodolfo C |
Device for treating diabetes and methods thereof
|
|
US8940292B2
(en)
|
2003-01-28 |
2015-01-27 |
Wake Forest University Health Sciences |
Enhancement of angiogenesis to grafts using cells engineered to produce growth factors
|
|
US20040197310A1
(en)
*
|
2003-02-12 |
2004-10-07 |
Sanberg Paul R. |
Compositions and methods for using umbilical cord progenitor cells in the treatment of myocardial infarction
|
|
EP1615996A4
(en)
*
|
2003-03-27 |
2006-11-15 |
Texase A & M University System |
USES OF VEGETABLE TOTHELIC GROWTH FACTOR AND COLLAGEN INDUCIBLE PROTEIN TYPE I (VCIP)
|
|
US8038991B1
(en)
|
2003-04-15 |
2011-10-18 |
Abbott Cardiovascular Systems Inc. |
High-viscosity hyaluronic acid compositions to treat myocardial conditions
|
|
US8383158B2
(en)
|
2003-04-15 |
2013-02-26 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions to treat myocardial conditions
|
|
US8821473B2
(en)
|
2003-04-15 |
2014-09-02 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions to treat myocardial conditions
|
|
US20040247575A1
(en)
*
|
2003-06-03 |
2004-12-09 |
Caplice Noel M. |
Smooth muscle progenitor cells
|
|
CA2539346A1
(en)
*
|
2003-09-17 |
2005-04-21 |
Macropore Biosurgery, Inc. |
Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
|
|
US9403908B2
(en)
*
|
2003-09-29 |
2016-08-02 |
The Regents Of The University Of California |
Method for altering hematopoietic progenitor cell adhesion, differentiation, and migration
|
|
US20090118817A1
(en)
*
|
2005-06-16 |
2009-05-07 |
Mayo Foundation For Medical Education And Research |
Magnetic Medical Apparatus, Kits, and Methods
|
|
US8465453B2
(en)
*
|
2003-12-03 |
2013-06-18 |
Mayo Foundation For Medical Education And Research |
Kits, apparatus and methods for magnetically coating medical devices with living cells
|
|
DE102004063927A1
(de)
*
|
2004-01-23 |
2005-12-15 |
Epoplus Gmbh Co.Kg |
Einsatz von niedrig dosiertem Erythropoietin zur Stimulation endothelialer Vorläuferzellen sowie zur Organregeneration und Progressionsverlangsamung von Endorganschäden
|
|
JP2007217283A
(ja)
*
|
2004-03-30 |
2007-08-30 |
Niigata Tlo:Kk |
血管新生促進剤および血管新生療法
|
|
EP2946666B1
(en)
*
|
2004-04-30 |
2017-11-15 |
OrbusNeich Medical, Inc. |
Medical device with coating for capturing genetically-altered cells and methods of using same
|
|
US20050265980A1
(en)
|
2004-05-14 |
2005-12-01 |
Becton, Dickinson And Company |
Cell culture environments for the serum-free expansion of mesenchymal stem cells
|
|
DK1759536T3
(da)
|
2004-06-01 |
2011-09-05 |
Kwalata Trading Ltd |
In vitro-teknikker til anvendelse med stamceller
|
|
ATE423842T1
(de)
*
|
2004-08-13 |
2009-03-15 |
Medtronic Inc |
Isolation der endothelvorläuferzellen-untermengen und verfahren zu ihrer verwendung
|
|
KR20070085288A
(ko)
*
|
2004-09-24 |
2007-08-27 |
안지오블라스트 시스템스 인코퍼레이티드 |
간엽 전구세포의 증식 및/또는 생존성 증강 방법
|
|
CA2582567A1
(en)
*
|
2004-10-07 |
2006-04-13 |
Stem Cell Therapeutics Corp. |
Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
|
|
EP1827494A4
(en)
*
|
2004-11-18 |
2010-02-17 |
Wayne Franco |
COMBINATION GROWTH THERAPY AND CELL THERAPY FOR THE TREATMENT OF ACUTE AND CHRONIC ORGANIC DISEASES
|
|
US20060110374A1
(en)
*
|
2004-11-24 |
2006-05-25 |
Dudy Czeiger |
Method to accelerate stem cell recruitment and homing
|
|
WO2006060779A2
(en)
*
|
2004-12-03 |
2006-06-08 |
Case Western Reserve University |
Novel methods, compositions and devices for inducing neovascularization
|
|
JP5138384B2
(ja)
*
|
2005-01-10 |
2013-02-06 |
サイトリ セラピューティクス インコーポレイテッド |
医療装置を監視し、管理し、サービスするための装置及び方法
|
|
US20090215782A1
(en)
*
|
2005-04-18 |
2009-08-27 |
Carlo Foresta |
Use of PDE-5 Inhibitors for Endothelial Repair of Tissues Impaired by Trauma or Disease
|
|
US20080125745A1
(en)
|
2005-04-19 |
2008-05-29 |
Shubhayu Basu |
Methods and compositions for treating post-cardial infarction damage
|
|
US9539410B2
(en)
|
2005-04-19 |
2017-01-10 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions for treating post-cardial infarction damage
|
|
US8828433B2
(en)
*
|
2005-04-19 |
2014-09-09 |
Advanced Cardiovascular Systems, Inc. |
Hydrogel bioscaffoldings and biomedical device coatings
|
|
FR2889200B1
(fr)
|
2005-07-27 |
2008-01-04 |
Inst Vaisseaux Et Du Sang Ass |
Systeme marqueur cellulaire/ligand, ou le marqueur est du type eph, materiau cellulaire comprenant ce systeme, procede de preparation et utilisation proangiogenique
|
|
US20070065514A1
(en)
*
|
2005-09-22 |
2007-03-22 |
Howell Mark D |
Method for enhancing immune responses in mammals
|
|
US7652922B2
(en)
*
|
2005-09-30 |
2010-01-26 |
Mosaid Technologies Incorporated |
Multiple independent serial link memory
|
|
US20070100323A1
(en)
*
|
2005-10-31 |
2007-05-03 |
Ludwig Florian N |
Facilitation of endothelialization by in situ surface modification
|
|
MY147516A
(en)
|
2005-11-07 |
2012-12-31 |
Amorcyte Inc |
Compositions and method of vascular injury repair cross-reference to related applications
|
|
US8637005B2
(en)
|
2005-11-07 |
2014-01-28 |
Amorcyte, Inc. |
Compositions and methods of vascular injury repair
|
|
US20110076255A1
(en)
|
2005-11-07 |
2011-03-31 |
Pecora Andrew L |
Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
|
|
TW200734462A
(en)
|
2006-03-08 |
2007-09-16 |
In Motion Invest Ltd |
Regulating stem cells
|
|
US7732190B2
(en)
|
2006-07-31 |
2010-06-08 |
Advanced Cardiovascular Systems, Inc. |
Modified two-component gelation systems, methods of use and methods of manufacture
|
|
US9242005B1
(en)
*
|
2006-08-21 |
2016-01-26 |
Abbott Cardiovascular Systems Inc. |
Pro-healing agent formulation compositions, methods and treatments
|
|
US20080075690A1
(en)
*
|
2006-09-22 |
2008-03-27 |
Mark Douglas Howell |
Method for enhancing immune responses in mammals
|
|
US20100034794A1
(en)
*
|
2006-10-03 |
2010-02-11 |
Van Der Strate Barry W A |
Endothelial progenitor cell compositions and neovascularization
|
|
WO2008085229A2
(en)
*
|
2006-11-15 |
2008-07-17 |
Arteriocyte Inc. |
Cell-based therapies for treating liver disease
|
|
US9005672B2
(en)
|
2006-11-17 |
2015-04-14 |
Abbott Cardiovascular Systems Inc. |
Methods of modifying myocardial infarction expansion
|
|
US8741326B2
(en)
|
2006-11-17 |
2014-06-03 |
Abbott Cardiovascular Systems Inc. |
Modified two-component gelation systems, methods of use and methods of manufacture
|
|
US8192760B2
(en)
|
2006-12-04 |
2012-06-05 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions for treating tissue using silk proteins
|
|
FR2909559B1
(fr)
*
|
2006-12-06 |
2012-09-07 |
Inst Vaisseaux Et Du Sang |
Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation
|
|
US20100040584A1
(en)
*
|
2006-12-19 |
2010-02-18 |
Children's Medical Center Corporation |
Methods for promoting neovascularization
|
|
US8137968B2
(en)
*
|
2007-02-28 |
2012-03-20 |
The Board Of Trustees Of The University Of Illinois |
Selected endothelial progenitor cells and methods for use
|
|
AU2008223817A1
(en)
*
|
2007-03-02 |
2008-09-12 |
National University Of Ireland, Galway |
Osteopontin for the prediction and treatment of cardiovascular diseases
|
|
US7632340B2
(en)
*
|
2007-03-07 |
2009-12-15 |
Hamilton Beach Brands, Inc. |
Air purifier for removing particles or contaminants from air
|
|
JP2010523496A
(ja)
|
2007-03-30 |
2010-07-15 |
ザ クリーブランド クリニック ファウンデーション |
虚血障害の治療方法
|
|
WO2008142862A1
(ja)
*
|
2007-05-18 |
2008-11-27 |
National University Corporation Asahikawa Medical College |
血管内皮前駆細胞の移植による抗がん療法
|
|
AU2008265973A1
(en)
*
|
2007-06-13 |
2008-12-24 |
Wake Forest University Health Sciences |
Methods of restoration of erectile function
|
|
US20090053208A1
(en)
*
|
2007-08-20 |
2009-02-26 |
Medtronic Vascular, Inc. |
Methods and Systems for Improving Tissue Perfusion
|
|
WO2009079451A2
(en)
|
2007-12-14 |
2009-06-25 |
The Cleveland Clinic Foundation |
Compositions and methods of promoting wound healing
|
|
US11051733B2
(en)
|
2008-01-18 |
2021-07-06 |
Wake Forest University Health Sciences |
Isolating and purifying cells for therapy
|
|
US20090246179A1
(en)
*
|
2008-02-11 |
2009-10-01 |
The Cleveland Clinic Foundation |
Method of treating myocardial injury
|
|
WO2010006219A2
(en)
*
|
2008-07-09 |
2010-01-14 |
Baxter International Inc. |
Use of scaffold comprising fibrin for delivery of stem cells
|
|
WO2010021993A1
(en)
|
2008-08-19 |
2010-02-25 |
Cytori Therapeutics, Inc. |
Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
|
|
CN102245189B
(zh)
*
|
2008-12-03 |
2015-06-17 |
阿莫塞特公司 |
改善梗死区灌注的组合物以及血管损伤修复方法
|
|
JP5725509B2
(ja)
|
2009-04-07 |
2015-05-27 |
国立大学法人旭川医科大学 |
単核球由来の新規血管再生細胞群及びその分化誘導法
|
|
KR101738324B1
(ko)
|
2009-05-01 |
2017-05-19 |
비미니 테크놀로지스 엘엘씨 |
조직 및 세포 부유화 이식편의 최적화 시스템, 방법 및 조성물
|
|
CA2772610C
(en)
|
2009-08-28 |
2018-01-23 |
The Cleveland Clinic Foundation |
Sdf-1 delivery for treating ischemic tissue
|
|
US20110091427A1
(en)
*
|
2009-10-02 |
2011-04-21 |
Baxter International Inc. |
Methods for treating a kidney injury
|
|
JP5709880B2
(ja)
|
2009-10-23 |
2015-04-30 |
アモーサイト インコーポレイテッド |
血管の機能不全による進行性心筋傷害治療のための組成物および方法
|
|
WO2012019168A2
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
RU2013120302A
(ru)
|
2010-10-01 |
2014-11-20 |
Модерна Терапьютикс, Инк. |
Сконструированные нуклеиновые кислоты и способы их применения
|
|
EP2625264B1
(en)
|
2010-10-08 |
2022-12-07 |
Terumo BCT, Inc. |
Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
|
|
AU2011325871B2
(en)
*
|
2010-11-05 |
2016-02-04 |
Medvet Science Pty Ltd |
Markers of endothelial progenitor cells and uses thereof
|
|
EP2663868A2
(en)
|
2010-12-01 |
2013-11-20 |
The University of North Carolina at Chapel Hill |
Methods and compositions for targeting sites of neovascular growth
|
|
EP2691101A2
(en)
|
2011-03-31 |
2014-02-05 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
RU2648950C2
(ru)
|
2011-10-03 |
2018-04-02 |
Модерна Терапьютикс, Инк. |
Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение
|
|
US9533010B2
(en)
|
2011-10-31 |
2017-01-03 |
Amorcyte, Llc |
Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
|
|
CN104114572A
(zh)
|
2011-12-16 |
2014-10-22 |
现代治疗公司 |
经修饰的核苷、核苷酸和核酸组合物
|
|
JP2015508101A
(ja)
|
2012-02-21 |
2015-03-16 |
バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ |
Ｃｄ３４＋細胞を含む薬学的組成物
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
AU2013243948A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins associated with human disease
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
WO2014081507A1
(en)
|
2012-11-26 |
2014-05-30 |
Moderna Therapeutics, Inc. |
Terminally modified rna
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
JP2016538829A
(ja)
|
2013-10-03 |
2016-12-15 |
モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
低密度リポタンパク質受容体をコードするポリヌクレオチド
|
|
JP6633522B2
(ja)
|
2013-11-16 |
2020-01-22 |
テルモ ビーシーティー、インコーポレーテッド |
バイオリアクターにおける細胞増殖
|
|
WO2015148704A1
(en)
|
2014-03-25 |
2015-10-01 |
Terumo Bct, Inc. |
Passive replacement of media
|
|
US20160090569A1
(en)
|
2014-09-26 |
2016-03-31 |
Terumo Bct, Inc. |
Scheduled Feed
|
|
WO2017004592A1
(en)
|
2015-07-02 |
2017-01-05 |
Terumo Bct, Inc. |
Cell growth with mechanical stimuli
|
|
JP7034949B2
(ja)
|
2016-05-25 |
2022-03-14 |
テルモ ビーシーティー、インコーポレーテッド |
細胞の増殖
|
|
US11104874B2
(en)
|
2016-06-07 |
2021-08-31 |
Terumo Bct, Inc. |
Coating a bioreactor
|
|
US11685883B2
(en)
|
2016-06-07 |
2023-06-27 |
Terumo Bct, Inc. |
Methods and systems for coating a cell growth surface
|
|
CN117247899A
(zh)
|
2017-03-31 |
2023-12-19 |
泰尔茂比司特公司 |
细胞扩增
|
|
US12234441B2
(en)
|
2017-03-31 |
2025-02-25 |
Terumo Bct, Inc. |
Cell expansion
|
|
US11624046B2
(en)
|
2017-03-31 |
2023-04-11 |
Terumo Bct, Inc. |
Cell expansion
|
|
GB2619893A
(en)
|
2021-03-23 |
2023-12-20 |
Terumo Bct Inc |
Cell capture and expansion
|
|
US12152699B2
(en)
|
2022-02-28 |
2024-11-26 |
Terumo Bct, Inc. |
Multiple-tube pinch valve assembly
|
|
USD1099116S1
(en)
|
2022-09-01 |
2025-10-21 |
Terumo Bct, Inc. |
Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device
|